Angle’s core strategy is “all about getting the best sample,” Angle CEO Andrew Newland explained at the 2021 Jefferies Healthcare Conference on 17 November.
“Cancer is heterogenous; it’s dynamic,” he said, explaining that for each individual patient, their disease will progress at different rates, with different side effects. “Each patient’s cancer is different from...